Zobrazeno 1 - 5
of 5
pro vyhledávání: '"59"'
Autor:
Pian Zhang, Dehui Zou, Yuqin Song, Hui Liu, Wenyu Li, Su Yang, Daobin Zhou, Zhitao Ying, Jun Zhu, Jianqiu Wu, Zhao Wang, Haiyan Yang, Mingzhi Zhang, Hongxia Zheng, Ye Guo, Zisong Zhou
Publikováno v:
Cancer Medicine, Vol 10, Iss 3, Pp 999-1011 (2021)
Cancer Medicine
Cancer Medicine
Background Despite numerous chimeric antigen receptor T‐cell (CAR‐T) trials conducted in China, no CAR‐T has been registered in the country. Furthermore, China law and regulations restrict the export of patient material for CAR‐T manufacture
Autor:
Gilles Robinet, Margaux Geier, Christos Chouaid, François Lucia, R. Lamy, Guillaume Léveiller, Romain Corre, Jean-Louis Bizec, Emilie Burte, Elisabeth Gaye, Karim Amrane, Cyril Bernier, Renaud Descourt, Éric Goarant, Gilles Quere
Publikováno v:
Cancer Medicine, Vol 9, Iss 19, Pp 6923-6932 (2020)
Cancer Medicine
Cancer Medicine
Background A standard of care for pretreated, advanced non–small‐cell lung cancers (NSCLCs), nivolumab has demonstrated long‐term benefit when administered for 2 years. We aimed to better discern an optimized administration duration by retrospe
Autor:
Kevin Diao, Jason C. Ye, Shelly X. Bian, Cheng Yu, Eric L. Chang, Jonathan L. Liu, Gabriel Zada, David M. Routman
Publikováno v:
Cancer Medicine
Stereotactic Radiosurgery (SRS) is considered standard of care for patients with 1–3 brain metastases (BM). Recent observational studies have shown equivalent OS in patients with 5+ BM compared to those with 2–4, suggesting SRS alone may be appro
Autor:
Qingsong Kang, Feibo Li, Diyu Huang, Yaojun Yu, Rui Ma, Xiao Liang, Jiang Chen, Xiujun Cai, Qiong Ding, Gaofeng Li, Hui Lin, Mingming Chen, Tong Ji
Publikováno v:
Cancer Medicine
In this paper, variation tendency of phosphorylated Nrf2, as the activated form of native Nrf2, was studied in 107 primary hepatocellular carcinoma (HCC) specimens treated by curative hepatectomy. Moreover, the coexpression of oxidative stress marker
Autor:
Suraj Manjunath, Kodaganur S. Gopinath, T.S. Sridhar, Savitha Rajarajan, Paul H. Weinreb, Msn Prasad, B.S. Srinath, Rekha V. Kumar, Shelia M. Violette, Rohini Kaluve, Radhika Aiyappa, Annie Alexander, M Correa, Raman N. Rao, Geetashree Mukherjee, Madhumathy G. Nair, Aruna Korlimarla, Krisha Desai, Anupama Vinod, Shekhar Patil, P.S. Hari, Jyothi S. Prabhu
Publikováno v:
Cancer Medicine
Integrin αvβ6 is involved in the transition from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) of the breast. In addition, integrin β6 (ITGB6) is of prognostic value in invasive breast cancers, particularly in HER2+ subtype. H